This guide is currently available in English. A Spanish version is in progress.
State ordering guide
Sourcing Exosomes in New Jersey
Licensed New Jersey practices order Kimera exosome material from ExaVeyra as research-grade product, shipped cold-chain from Miami Beach with a Certificate of Analysis and lot traceability on every vial. New Jersey buyers need their own professional license and NPI; the wholesale distributor registration is the supplier’s obligation, not the purchaser’s.
Two New Jersey specifics are worth settling before you set up. Wholesale registration runs through the Department of Health rather than the pharmacy board, and the state is unusually strict about who may perform the examination that authorises a treatment.
At a glance
| Question | Answer |
|---|---|
| Does ExaVeyra ship to New Jersey? | Yes. Cold-chain from Miami Beach, as we do to all 50 states |
| Cold-chain transit from Miami | 1 to 3 business days |
| State regenerative-medicine statute | None |
| Does that statute reach exosomes? | No. It covers cells and tissues; exosomes are governed federally |
| Physician delegation required to hand off medical acts | Yes |
| Who holds the wholesale distribution permit | The supplier, not the purchasing practice |
| Last reviewed | 9 August 2026 |
Ordering from New Jersey
ExaVeyra ships to licensed practices in all 50 states, New Jersey included. Distribution-side licensing is handled by us, so your practice orders against its own professional license and NPI. What varies state to state is not whether product can reach you, but the indications it may be used for under federal law and how New Jersey regulates who performs the procedure.
What your practice provides
- An active New Jersey professional license in good standing, verifiable through the Division of Consumer Affairs.
- A valid NPI, which ExaVeyra verifies at account setup.
- A signed research-use acknowledgment on file for exosome material.
- A New Jersey resale certificate (form ST-3) if the practice is purchasing for resale rather than for use in its own operations.
How the state permits wholesale distribution
New Jersey registers wholesale drug and device distributors through the Department of Health rather than through the pharmacy board, which catches out distributors used to dealing with a board of pharmacy elsewhere. Registration covers devices as well as drugs and carries a bond requirement. New Jersey also permits an out-of-state wholesale distributor to satisfy the requirement on a reciprocity basis where it holds a valid licence or registration from another state issued under standards comparable to New Jersey’s, which is a route no other state in these guides offers. The registration sits with the distributor, not with the purchasing practice.
N.J.S.A. 24:6B-2 · New Jersey Department of Health, Drug and Medical Device Program
New Jersey regenerative-medicine law
New Jersey has not enacted a statute specific to stem cell or regenerative therapies. Practice in this area is governed by the state's general medical practice and professional licensing rules, alongside federal law.
What fills the gap in New Jersey is enforcement rather than legislation. The State Board of Medical Examiners and the Board of Nursing both scrutinise documented oversight, and the practical exposure for an aesthetic practice is a lapse in delegation records rather than a breach of any regenerative-medicine statute. Practices are expected to keep delegation orders and supervision logs current and to renew protocols at least annually or whenever a new treatment is adopted.
How this applies to exosomes
New Jersey has not enacted a stem cell authorization law like Florida, Texas, or Georgia, a disclosure law like California, or a documentation statute like Tennessee. There is therefore no state definition to read exosomes into or out of. Exosome products are governed by federal law, under which no exosome product has been approved by the FDA for administration to humans. The practical consequence in New Jersey is that the delegation and examination rules do the work a regenerative-medicine statute would do elsewhere, and those rules are enforced attentively. ExaVeyra supplies Kimera material for topical aesthetic use in clinics and for research applications, with full COA and lot documentation.
Who can handle product in a New Jersey practice
New Jersey runs on documented delegation rather than informal practice. Delegation orders and supervision logs are kept current, protocols are renewed at least annually or whenever a new treatment is adopted, and both the Board of Medical Examiners and the Board of Nursing examine those records. The most common failure is not an absent protocol but a stale one.
| Role | Scope under state law |
|---|---|
| MD / DO | Physicians licensed by the State Board of Medical Examiners may perform medical acts within their scope and are the source of any delegation. New Jersey expects the physician to retain final authority over clinical and safety decisions rather than delegating that authority along with the task. |
| NP / APRN | Advanced practice nurses may perform the examination, review findings, and write the treatment plan and order, within their scope. |
| PA | Physician assistants may perform the examination and write the plan and order within the scope their supervising physician delegates. |
| RN | Registered nurses may administer medical aesthetic treatments including injectables when delegated by a physician and operating under established protocols, and the delegation must be documented. An RN may gather history and assist with the examination, but may not perform the examination itself or generate the treatment order. |
Good faith examination
New Jersey draws this line more sharply than most states. A physician, physician assistant, or advanced practice nurse performs the good faith examination, reviews the findings, and writes the plan and order. A registered nurse may gather history and assist, and may administer under a valid order, but may not perform the examination or write the order, because doing so would be the practice of medicine.
Ownership and clinic licensing
New Jersey enforces the corporate practice of medicine doctrine strictly, and non-physicians may not own or control a medical practice. The professional practice structure rules in the administrative code govern the permitted forms, and non-physician investors participate through a management services organisation providing administrative services at fair market value. The fair-market-value qualifier matters: an MSO fee structured as a share of clinical revenue is the arrangement most likely to draw attention. Structure this with New Jersey counsel before opening.
Cold chain into New Jersey
Shipments dispatch from our Miami Beach facility under validated temperature monitoring, and delivery into New Jersey is scheduled to avoid a weekend hold at the carrier hub.
| Metro | County | Notes |
|---|---|---|
| Newark | Essex | Largest city and a dense clinical market. |
| Jersey City | Hudson | Fast-growing aesthetic segment across the Hudson waterfront. |
| Hoboken | Hudson | Compact, high-density med spa corridor. |
| Princeton | Mercer | Concierge and longevity practices in central New Jersey. |
| Paramus | Bergen | North Jersey aesthetic hub serving the New York border. |
| Cherry Hill | Camden | South Jersey market serving the Philadelphia corridor. |
- New Jersey orders of fifteen or more cold-chain units ship free nationwide; see the volume program for current thresholds.
- Inspect the temperature indicator on arrival and contact us before use if the shipment reads outside range.
- Storage and handling conditions for each product are stated on its Certificate of Analysis.
Practice types we supply in New Jersey
New Jersey licensing and verification
New Jersey State Board of Medical Examiners
Physician license verification and the professional practice structure rules.
New Jersey Board of Nursing
NJ Department of Health, Drug and Medical Device Program
Registers wholesale drug and device distributors shipping into New Jersey.
New Jersey Division of Taxation
Where a practice registers before issuing a resale certificate.
New Jersey sourcing questions
- Does New Jersey have a stem cell law covering exosomes?
- No. New Jersey has no stem cell authorization law, no disclosure law, and no documentation statute of the kind Tennessee enacted, so there is no state definition to read exosomes into or out of. Exosome products are governed federally, and no exosome product is FDA-approved for administration to humans. In New Jersey the delegation and examination rules do the work a regenerative-medicine statute would do elsewhere.
- Can a registered nurse perform the good faith exam in New Jersey?
- No. A physician, physician assistant, or advanced practice nurse performs the examination, reviews the findings, and writes the plan and order. An RN may gather history and assist, and may administer under a valid order, but performing the examination or writing the order would be the practice of medicine. New Jersey draws this line more sharply than most states.
- Can a non-physician own a med spa in New Jersey?
- Not the medical practice. New Jersey enforces the corporate practice of medicine doctrine strictly, and non-physician investors participate through a management services organisation providing administrative services at fair market value. An MSO fee structured as a share of clinical revenue is the arrangement most likely to attract scrutiny. Structure this with New Jersey counsel.
- Which agency registers wholesale distributors in New Jersey?
- The Department of Health, through its Drug and Medical Device Program, rather than the pharmacy board. Registration covers devices as well as drugs and carries a bond requirement. New Jersey also allows an out-of-state distributor to satisfy the requirement on a reciprocity basis where its home state licence was issued under comparable standards.
- Does my New Jersey clinic need that registration to buy exosomes?
- No. The wholesale drug and device distributor registration under N.J.S.A. 24:6B-2 is held by the distributor shipping into New Jersey, not by the practice buying. Your practice orders against its own professional license and NPI. ExaVeyra handles distribution-side registration.
- How long does cold-chain shipping take to New Jersey?
- Overnight from our Miami Beach facility once prepared, with preparation taking one to two business days. All exosome shipments travel cold-chain with validated temperature monitoring, and deliveries are scheduled to avoid a weekend hold at the carrier hub.
Sources
Last reviewed 9 August 2026 by ExaVeyra Sciences editorial team. Every claim above links to a primary source.
- NJ Department of Health, Drug and Medical Device Program (accessed 8 August 2026)
- New Jersey State Board of Medical Examiners (accessed 8 August 2026)
- New Jersey Board of Nursing (accessed 8 August 2026)
- New Jersey Division of Taxation (accessed 8 August 2026)
- FDA Public Safety Notification on Exosome Products (accessed 8 August 2026)
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. There are no FDA-approved exosome products. Biomolecular signaling vesicle products distributed by ExaVeyra Sciences are supplied for topical aesthetic treatments in clinics and for medical, molecular biology, and biochemistry research applications, and are not tissue products as defined by FDA guidelines.
This page summarizes publicly available state requirements for licensed practitioner education. It is not legal advice, medical advice, or regulatory guidance, and it does not establish that any particular practice is compliant. Requirements change. Confirm current federal and state obligations with qualified counsel before offering any regenerative service line.